
publicrelations@venrock.com
For verified host and producer emails, sign up to view.
Episodes: 100
Frequency: Irregular
Rating: 4.7/5.0
Estimated listeners: 1k-10k
Gender skew: Male
Location: USA
publicrelations@venrock.com
For verified host and producer emails, sign up to view.
Bryan Roberts - Not specified in the provided text beyond being a participant in the episode “Healthcare Prognosis 2026” with Venrock.
Bob Kocher - Not specified in the provided text beyond being a participant in the episode “Healthcare Prognosis 2026” with Venrock.
Siobhan Nolan Mangini - Not specified in the provided text beyond being a participant in the episode “Healthcare Prognosis 2026” with Venrock.
Nick Beim - Co-interviewer/participant on the episode “Arca's AI-First Vision for Human-First Wealth Management,” featuring Venrock.
Nimish Shah - Co-interviewer/participant on the episode “Building a Differentiated Obesity Biotech,” featuring Venrock.
Rron Rexha - Ai-native Wealth Management; Vision For Human-first Advice; Journey And Reflections On Time As An Entrepreneur-in-residence At Venrock
Whit Bernard - Ultra-long Acting Glp-1 Program; Positioning In Obesity Market; Pharma Competition; Lessons In First-principles Biotech Building
Healthcare Prognosis 2026
June 30, 2026
The results of Venrock's 10th annual Healthcare Prognosis are in. This year's survey covers some of the biggest questions in healthcare, from AI in medical care and the future of GLP-1s to consumer peptides, IPOs, M&A, and what's ahead for healthcare policy. In this episode, Bryan Roberts, Bob Kocher, and Siobhan Nolan Mangini sit down to discuss the most interesting findings, share their perspectives on what surprised them, and offer a pulse check on where the industry may be headed next.
Arca's AI-First Vision for Human-First Wealth Management
June 25, 2026
As Arca launches with $64 million in funding and more than $1 billion in assets under management, founder and CEO Rron Rexha joins Nick Beim to share his vision for AI-native wealth management built around human-first advice. Rron reflects on his journey from Kosovo to fintech, his year as an Entrepreneur-in-Residence at Venrock, and why he believes the next era of wealth management will be more proactive, personalized, and accessible.
Building a Differentiated Obesity Biotech
June 23, 2026
Metsera CEO Whit Bernard joins Venrock's Nimish Shah to discuss how the company's ultra-long acting GLP-1 program helped position it as a strategic standout in the obesity market. The conversation covers the bidding war between major pharma players, lessons in first-principles company building, and why the next decade of biotech could reward high-volume, accessible innovation.
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings